Cargando…

Serum Pharmacochemistry Combining Network Pharmacology to Discover the Active Constituents and Effect of Xijiao Dihuang Tang Prescription for Treatment of Blood-Heat and Blood-Stasis Syndrome-Related Disease

Xijiao Dihuang Tang (XDT), a classic TCM prescription, has been used to clinically treat blood-heat and blood-stasis syndrome- (BHSS-) related diseases, including hemorrhagic stroke and sepsis. However, the active constituents and mechanism of XDT in the treatment of BHSS-related diseases have not b...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yuxin, Dai, Yang, Xia, Jie, Liu, Jing, Zhou, Guisheng, Chen, Cuihua, Jiang, Baoping, Yin, Lian, Li, Guochun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8845118/
https://www.ncbi.nlm.nih.gov/pubmed/35178159
http://dx.doi.org/10.1155/2022/6934812
_version_ 1784651604029341696
author Chen, Yuxin
Dai, Yang
Xia, Jie
Liu, Jing
Zhou, Guisheng
Chen, Cuihua
Jiang, Baoping
Yin, Lian
Li, Guochun
author_facet Chen, Yuxin
Dai, Yang
Xia, Jie
Liu, Jing
Zhou, Guisheng
Chen, Cuihua
Jiang, Baoping
Yin, Lian
Li, Guochun
author_sort Chen, Yuxin
collection PubMed
description Xijiao Dihuang Tang (XDT), a classic TCM prescription, has been used to clinically treat blood-heat and blood-stasis syndrome- (BHSS-) related diseases, including hemorrhagic stroke and sepsis. However, the active constituents and mechanism of XDT in the treatment of BHSS-related diseases have not been elucidated due to the lack of appropriate methodologies. In this study, serum pharmacochemistry and network pharmacology were used to explore the active constituents and the mechanism of XDT in the treatment of BHSS-related diseases. The effects of XDT were evaluated using dry yeast-induced rats as rat models with BHSS, which demonstrated the antipyretic and anticoagulant properties of XDT. The HPLC-QTOF/MS/MS assay was used to identify 60 serum constituents of XDT (SCXDT). Then, 338 targets of 60 SCXDT were predicted by integrating multiple databases and the MACCS fingerprint similarity prediction method. The degree of topological properties with targets of 19 key active constituents in SCXDT was identified and evaluated in glutamate-induced PC12 cells. Subsequently, 338 targets of 60 SCXDT were mainly involved in biological processes such as inflammation, coagulation, cell proliferation, and apoptosis, as well as oxidative contingencies via compound-target-disease network analysis. The core targets including IL-1β, IL-6, TNF, NOS3, and MAPK1 were identified using protein-protein interaction network analysis, whereas dozens of signaling pathways such as the p38MAPK signaling pathway were identified using functional pathway enrichment analysis. The results indicated that XDT has broad therapeutic and neuroprotective effects on inflammation, coagulation, oxidative stress, cell proliferation, and apoptosis in dry yeast-induced rats with BHSS and glutamate-induced PC12 cells by regulating the p38MAPK signaling pathway. This study not only discovered the active constituents of XDT but also elaborated its mechanisms in the treatment of BHSS-related diseases by intervening in a series of targets, signaling pathways, and biological processes such as inflammation, coagulation, oxidative stress, neuroprotection. The findings in this study provide a novel strategy for exploring the therapeutic efficacy of TCM prescriptions.
format Online
Article
Text
id pubmed-8845118
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-88451182022-02-16 Serum Pharmacochemistry Combining Network Pharmacology to Discover the Active Constituents and Effect of Xijiao Dihuang Tang Prescription for Treatment of Blood-Heat and Blood-Stasis Syndrome-Related Disease Chen, Yuxin Dai, Yang Xia, Jie Liu, Jing Zhou, Guisheng Chen, Cuihua Jiang, Baoping Yin, Lian Li, Guochun Oxid Med Cell Longev Research Article Xijiao Dihuang Tang (XDT), a classic TCM prescription, has been used to clinically treat blood-heat and blood-stasis syndrome- (BHSS-) related diseases, including hemorrhagic stroke and sepsis. However, the active constituents and mechanism of XDT in the treatment of BHSS-related diseases have not been elucidated due to the lack of appropriate methodologies. In this study, serum pharmacochemistry and network pharmacology were used to explore the active constituents and the mechanism of XDT in the treatment of BHSS-related diseases. The effects of XDT were evaluated using dry yeast-induced rats as rat models with BHSS, which demonstrated the antipyretic and anticoagulant properties of XDT. The HPLC-QTOF/MS/MS assay was used to identify 60 serum constituents of XDT (SCXDT). Then, 338 targets of 60 SCXDT were predicted by integrating multiple databases and the MACCS fingerprint similarity prediction method. The degree of topological properties with targets of 19 key active constituents in SCXDT was identified and evaluated in glutamate-induced PC12 cells. Subsequently, 338 targets of 60 SCXDT were mainly involved in biological processes such as inflammation, coagulation, cell proliferation, and apoptosis, as well as oxidative contingencies via compound-target-disease network analysis. The core targets including IL-1β, IL-6, TNF, NOS3, and MAPK1 were identified using protein-protein interaction network analysis, whereas dozens of signaling pathways such as the p38MAPK signaling pathway were identified using functional pathway enrichment analysis. The results indicated that XDT has broad therapeutic and neuroprotective effects on inflammation, coagulation, oxidative stress, cell proliferation, and apoptosis in dry yeast-induced rats with BHSS and glutamate-induced PC12 cells by regulating the p38MAPK signaling pathway. This study not only discovered the active constituents of XDT but also elaborated its mechanisms in the treatment of BHSS-related diseases by intervening in a series of targets, signaling pathways, and biological processes such as inflammation, coagulation, oxidative stress, neuroprotection. The findings in this study provide a novel strategy for exploring the therapeutic efficacy of TCM prescriptions. Hindawi 2022-02-07 /pmc/articles/PMC8845118/ /pubmed/35178159 http://dx.doi.org/10.1155/2022/6934812 Text en Copyright © 2022 Yuxin Chen et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Chen, Yuxin
Dai, Yang
Xia, Jie
Liu, Jing
Zhou, Guisheng
Chen, Cuihua
Jiang, Baoping
Yin, Lian
Li, Guochun
Serum Pharmacochemistry Combining Network Pharmacology to Discover the Active Constituents and Effect of Xijiao Dihuang Tang Prescription for Treatment of Blood-Heat and Blood-Stasis Syndrome-Related Disease
title Serum Pharmacochemistry Combining Network Pharmacology to Discover the Active Constituents and Effect of Xijiao Dihuang Tang Prescription for Treatment of Blood-Heat and Blood-Stasis Syndrome-Related Disease
title_full Serum Pharmacochemistry Combining Network Pharmacology to Discover the Active Constituents and Effect of Xijiao Dihuang Tang Prescription for Treatment of Blood-Heat and Blood-Stasis Syndrome-Related Disease
title_fullStr Serum Pharmacochemistry Combining Network Pharmacology to Discover the Active Constituents and Effect of Xijiao Dihuang Tang Prescription for Treatment of Blood-Heat and Blood-Stasis Syndrome-Related Disease
title_full_unstemmed Serum Pharmacochemistry Combining Network Pharmacology to Discover the Active Constituents and Effect of Xijiao Dihuang Tang Prescription for Treatment of Blood-Heat and Blood-Stasis Syndrome-Related Disease
title_short Serum Pharmacochemistry Combining Network Pharmacology to Discover the Active Constituents and Effect of Xijiao Dihuang Tang Prescription for Treatment of Blood-Heat and Blood-Stasis Syndrome-Related Disease
title_sort serum pharmacochemistry combining network pharmacology to discover the active constituents and effect of xijiao dihuang tang prescription for treatment of blood-heat and blood-stasis syndrome-related disease
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8845118/
https://www.ncbi.nlm.nih.gov/pubmed/35178159
http://dx.doi.org/10.1155/2022/6934812
work_keys_str_mv AT chenyuxin serumpharmacochemistrycombiningnetworkpharmacologytodiscovertheactiveconstituentsandeffectofxijiaodihuangtangprescriptionfortreatmentofbloodheatandbloodstasissyndromerelateddisease
AT daiyang serumpharmacochemistrycombiningnetworkpharmacologytodiscovertheactiveconstituentsandeffectofxijiaodihuangtangprescriptionfortreatmentofbloodheatandbloodstasissyndromerelateddisease
AT xiajie serumpharmacochemistrycombiningnetworkpharmacologytodiscovertheactiveconstituentsandeffectofxijiaodihuangtangprescriptionfortreatmentofbloodheatandbloodstasissyndromerelateddisease
AT liujing serumpharmacochemistrycombiningnetworkpharmacologytodiscovertheactiveconstituentsandeffectofxijiaodihuangtangprescriptionfortreatmentofbloodheatandbloodstasissyndromerelateddisease
AT zhouguisheng serumpharmacochemistrycombiningnetworkpharmacologytodiscovertheactiveconstituentsandeffectofxijiaodihuangtangprescriptionfortreatmentofbloodheatandbloodstasissyndromerelateddisease
AT chencuihua serumpharmacochemistrycombiningnetworkpharmacologytodiscovertheactiveconstituentsandeffectofxijiaodihuangtangprescriptionfortreatmentofbloodheatandbloodstasissyndromerelateddisease
AT jiangbaoping serumpharmacochemistrycombiningnetworkpharmacologytodiscovertheactiveconstituentsandeffectofxijiaodihuangtangprescriptionfortreatmentofbloodheatandbloodstasissyndromerelateddisease
AT yinlian serumpharmacochemistrycombiningnetworkpharmacologytodiscovertheactiveconstituentsandeffectofxijiaodihuangtangprescriptionfortreatmentofbloodheatandbloodstasissyndromerelateddisease
AT liguochun serumpharmacochemistrycombiningnetworkpharmacologytodiscovertheactiveconstituentsandeffectofxijiaodihuangtangprescriptionfortreatmentofbloodheatandbloodstasissyndromerelateddisease